- Home
- FNLC vs OSUR Comparison
FNLC vs OSUR Comparison
Compare FNLC & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- OSUR
- Stock Information
- Founded
- FNLC 1864
- OSUR 2000
- Country
- FNLC United States
- OSUR United States
- Employees
- FNLC N/A
- OSUR N/A
- Industry
- FNLC Major Banks
- OSUR Medical/Dental Instruments
- Sector
- FNLC Finance
- OSUR Health Care
- Exchange
- FNLC Nasdaq
- OSUR Nasdaq
- Market Cap
- FNLC 284.1M
- OSUR 284.9M
- IPO Year
- FNLC 1999
- OSUR 1986
- Fundamental
- Price
- FNLC $24.51
- OSUR $3.41
- Analyst Decision
- FNLC
- OSUR Hold
- Analyst Count
- FNLC 0
- OSUR 2
- Target Price
- FNLC N/A
- OSUR $5.50
- AVG Volume (30 Days)
- FNLC 19.8K
- OSUR 1.0M
- Earning Date
- FNLC 04-16-2025
- OSUR 05-07-2025
- Dividend Yield
- FNLC 5.85%
- OSUR N/A
- EPS Growth
- FNLC N/A
- OSUR N/A
- EPS
- FNLC 2.43
- OSUR N/A
- Revenue
- FNLC $79,740,000.00
- OSUR $185,827,000.00
- Revenue This Year
- FNLC N/A
- OSUR N/A
- Revenue Next Year
- FNLC N/A
- OSUR $8.41
- P/E Ratio
- FNLC $10.23
- OSUR N/A
- Revenue Growth
- FNLC 0.35
- OSUR N/A
- 52 Week Low
- FNLC $21.77
- OSUR $2.69
- 52 Week High
- FNLC $31.05
- OSUR $7.13
- Technical
- Relative Strength Index (RSI)
- FNLC 36.81
- OSUR 44.59
- Support Level
- FNLC $24.34
- OSUR $3.34
- Resistance Level
- FNLC $26.38
- OSUR $3.54
- Average True Range (ATR)
- FNLC 0.55
- OSUR 0.22
- MACD
- FNLC -0.11
- OSUR -0.00
- Stochastic Oscillator
- FNLC 8.33
- OSUR 51.80
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.